ArticleOncogene2026

In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis.

Anna F Fajardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.